Abstract:Background Tuberculosis (TB) remains a major public health concern worldwide. Previous studies have demonstrated that IL-17 plays an important role in initial immune response and is involved in both immune-mediated protection and pathology following infection with Mycobacterium tuberculosis (MTB). However, the alterations and regulation of plasma IL-17 level during TB treatment remain unclear. Moreover, the cell type responsible for the production of IL-17 in TB patients requires further study. Methods A total of 20 acid-fast bacilli smear-positive (AFB-positive) pulmonary TB patients and 20 age- and gender-matched healthy volunteers were included in our study. Blood samples were collected in heparinized tubes at the time of diagnosis (AFB-positive group) and 3 weeks after the initiation of therapy, when the sputum smear conversion (AFB-negative group) occurred, followed by symptomatic improvement. IL-17 levels and IL-17-producing cells in PBMCs were detected. Lymphocyte populations in the peripheral blood between the AFB-positive and AFB-negative groups were compared by flow-cytometry. A549 cells, a cell line of alveolar epithelial cells, were applied to determine the extent of the pathological damage mediated by IL-17 following MTB infection. Recombinant human IL-10 was used to investigate the regulation of IL-17 expression after sputum smear conversion in AFB-positive pulmonary TB patients. Results Plasma IL-17 level were elevated in patients with sputum AFB-positive pulmonary TB, but substantially decreased after TB treatment and smear conversion. Our data indicate that NKT-like cells might be the main source of IL-17, in addition to conventional T cells in AFB-positive pulmonary TB patients. The secretion of IL-17 may be suppressed by regulatory T (Treg) cells and IL-10 during TB treatment. Moreover, the IL-17 levels were positively correlated to both the C-reactive protein and erythrocyte sedimentation rate. Therefore, IL-17 was capable of alveolar epithelial cell damage following MTB infection. Conclusion The increase in the frequency of Treg cells and IL-10 levels was associated with a decrease in IL-17 in patients receiving TB treatment. Thus, IL-10 and Tregs may function to inhibit immune-mediated pathology in TB patients.

IL-10-producing B Cells Regulate Th1/Th17-cell Immune Responses in Pneumocystis Pneumonia.

Circulating And Pulmonary T-Cell Populations Driving The Immune Response In Non-Hiv Immunocompromised Patients With Pneumocystis Jirovecii Pneumonia

Imbalance of Th17 Cells and Regulatory T Cells in Tuberculous Pleural Effusion.

Apnalysis of lncRNA and mRNA Repertoires in Lung From BAFF-R-Deficient Pneumocystis-Infected Mice

Loss of regulatory characteristics in CD4 + CD25 +/hi T cells induced by impaired transforming growth factor beta secretion in pneumoconiosis.

Neutrophil responsiveness to IL-10 impairs clearance of Streptococcus pneumoniae from the lungs

MyD88 signaling regulates both host defense and immunopathogenesis during pneumocystis infection

Decreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10

Interaction between Pneumocystis jirovecii and host immune defense

[Immune Response in Pneumocystis Carinii Pneumonia in Rats].

T Cell Responses in Senior Patients with Community-Acquired Pneumonia Related to Disease Severity.

CD4+CD25+ T regulatory cells dampen inflammatory responses in murine mycoplasma pneumonia and are associated with promotion of IL-17 AND IFN-γ production, but not IL-10 or TGF-β. (P3055)

IL17-Producing Γδ T Cells May Enhance Humoral Immunity During Pulmonary Pseudomonas Aeruginosa Infection in Mice

CD40 Expression by B cells is Required for Optimal Immunity to Murine Pneumocystis Infection

The Critical Role of Induced CD4+ FoxP3+ Regulatory Cells in Suppression of Interleukin-17 Production and Attenuation of Mouse Orthotopic Lung Allograft Rejection.

IL-17 Regulate the Polarization of Macrophages to Promote the Development of Obliterative Bronchiolitis in Murine Trachea Transplantation Model

ROS-induced metabolic reprogramming to one-carbon metabolism and S-adenosylmethionine-mediated epigenetic modification in IL-10-producing B cells for the resolution of pneumonia

Metabolomic Profiling of Lungs from Mice Reveals the Variability of Metabolites in Pneumocystis Infection and the Metabolic Abnormalities in BAFF-R-Deficient Mice

Allergic airway inflammation disrupts interleukin-17 mediated host defense against streptococcus pneumoniae infection

Single-Cell TCR Sequencing Reveals the Dynamics of T Cell Repertoire Profiling During Pneumocystis Infection

Proteomic Profiling and Functional Analysis of B Cell-Derived Exosomes upon Pneumocystis Infection